Skip to Content
Stock Analyst Update

Red Hat Still a Bright Spot for IBM Amid COVID-19

IBM continued to refrain from publishing an outlook for the quarter or full year, but we expect the final quarter will see strong sequential growth due to IBM’s seasonality despite another expected quarter of annual declines. We’ve also increased our expectations for the year, leading us to raise our fair value estimate for the narrow-moat name to $125 per share from $120.

Mentioned:

 

IBM (IBM) reported a third consecutive quarter of revenue declines in its third quarter results, although top-line results were above our former expectations--as Red Hat continued to be a lone growth driver--and IBM’s non-GAAP earnings were in line with CapIQ consensus. Earnings came over a week after IBM announced its plans to spin off its managed infrastructure services businesses. Nonetheless, little new information was given on the spin-off expected for 2021. Still, we continue to think the spin-off is beneficial more in optics--as it should allow IBM’s overall top-line growth to look better by divesting the large but dwindling segment. IBM continued to refrain from publishing an outlook for the quarter or full year, but we expect the final quarter will see strong sequential growth due to IBM’s seasonality despite another expected quarter of annual declines. We’ve also increased our expectations for the year, leading us to raise our fair value estimate for the narrow-moat name to $125 per share from $120. Shares are down 3% to $122 per share upon the news, implying that IBM’s stock is fairly valued, in our view.

In the third quarter, total revenue declined by 3% year over year to $17.6 billion. IBM’s cloud & cognitive software revenue rose by 7% year over year, benefiting from a mix shift away from transactional software, which was disproportionately dragged by COVID-19. In the segment, Red Hat revenue increased by 17% year over year, propping up overall segment growth. Global technology services revenue decreased by 4% year over year as a result of IBM’s hardware product cycle and pandemic related weakness. Global business services revenue decreased by 5% year over year due to project delays caused by COVID-19 and, relatedly, enterprises staying cautious about discretionary spend. Systems revenue decreased by 15% year over year, which is in line with the cadence of typical product cycles. Financing revenue decreased by 20% year over year.

 

Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.

Julie Bhusal Sharma does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.